BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morisky DE, Ebin VJ, Malotte CK, Coly A, Kominski G. Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources. Implications for treatment interventions. Eval Health Prof 2003;26:43-58. [PMID: 12629921 DOI: 10.1177/0163278702250080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Campbell JI, Sandora TJ, Haberer JE. A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking. BMJ Glob Health 2021;6:e004836. [PMID: 34016576 DOI: 10.1136/bmjgh-2020-004836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Sugishita Y, Goto C, Sakamoto T, Sugawara T, Ohkusa Y. Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo, Japan. J Infect Chemother 2020;26:1129-33. [PMID: 32839113 DOI: 10.1016/j.jiac.2020.05.007] [Reference Citation Analysis]
3 Liu Y, Birch S, Newbold KB, Essue BM. Barriers to treatment adherence for individuals with latent tuberculosis infection: A systematic search and narrative synthesis of the literature. Int J Health Plann Mgmt 2017;33:e416-33. [DOI: 10.1002/hpm.2495] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
4 Haley CA. Treatment of Latent Tuberculosis Infection. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch6] [Reference Citation Analysis]
5 Haley CA. Treatment of Latent Tuberculosis Infection. Microbiol Spectr 2017;5. [PMID: 28409555 DOI: 10.1128/microbiolspec.TNMI7-0039-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
6 Stuurman AL, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ. Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis 2016;16:257. [PMID: 27268103 DOI: 10.1186/s12879-016-1549-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
7 Sandgren A, Vonk Noordegraaf-Schouten M, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis 2016;16:204. [PMID: 27184748 DOI: 10.1186/s12879-016-1550-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
8 Guo N, Marra CA, FitzGerald JM, Elwood RK, Anis AH, Marra F. Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment. Value Health 2011;14:937-43. [PMID: 21914516 DOI: 10.1016/j.jval.2011.05.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
9 Minodier P, Lamarre V, Carle ME, Blais D, Ovetchkine P, Tapiero B. Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children. J Infect Public Health 2010;3:67-75. [PMID: 20701894 DOI: 10.1016/j.jiph.2010.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
10 Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-moverman Y, Hughes S, Shrestha-kuwahara R, Sterling TR, Wall K, Weinfurter P. Latent TB Infection Treatment Acceptance and Completion in the United States and Canada. Chest 2010;137:401-9. [DOI: 10.1378/chest.09-0394] [Cited by in Crossref: 143] [Cited by in F6Publishing: 151] [Article Influence: 11.0] [Reference Citation Analysis]
11 . Practice Notes: Strategies in Health Education. Health Educ Behav 2009;36:805-9. [DOI: 10.1177/1090198109343418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Hill L, Blumberg E, Sipan C, Schmitz K, West J, Kelley N, Hovell M. Multi-level barriers to LTBI treatment: a research note. J Immigr Minor Health 2010;12:544-50. [PMID: 19085104 DOI: 10.1007/s10903-008-9216-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ailinger RL, Black P, Nguyen N, Lasus H. Predictors of adherence to latent tuberculosis infection therapy in Latino immigrants. J Community Health Nurs 2007;24:191-8. [PMID: 17650988 DOI: 10.1080/07370010701429637] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
14 Kim S, Crittenden K. Treatment Completion Among TB Patients Returned To The Community From A Large Urban Jail. J Community Health 2007;32:135-47. [DOI: 10.1007/s10900-006-9036-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kominski GF, Varon SF, Morisky DE, Malotte CK, Ebin VJ, Coly A, Chiao C. Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial. J Adolesc Health 2007;40:61-8. [PMID: 17185207 DOI: 10.1016/j.jadohealth.2006.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
16 Ailinger RL, Moore JB, Nguyen N, Lasus H. Adherence to latent tuberculosis infection therapy among latino immigrants. Public Health Nurs 2006;23:307-13. [PMID: 16817801 DOI: 10.1111/j.1525-1446.2006.00566.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
17 Parsyan AE, Saukkonen J, Barry MA, Sharnprapai S, Horsburgh CR Jr. Predictors of failure to complete treatment for latent tuberculosis infection. J Infect 2007;54:262-6. [PMID: 16772095 DOI: 10.1016/j.jinf.2006.04.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
18 Pelly T, Moore DA, Gilman R, Evans C. Recent tuberculosis advances in Latin America. Curr Opin Infect Dis 2004;17:397-403. [PMID: 15353958 DOI: 10.1097/00001432-200410000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]